Astraea Therapeutics, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Astraea Therapeutics, LLC
Quantité totale PI 12
Rang # Quantité totale PI 129 563
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 241 220
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

7 1
2 0
2 0
0
 
Dernier brevet 2024 - Piperidinyl nociceptin receptor ...
Premier brevet 2011 - Nicotinic acetylcholine receptor...
Dernière marque 2021 - ASTRAEA THERAPEUTICS.
Première marque 2021 - ASTRAEA THERAPEUTICS.

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Piperidinyl nociceptin receptor compounds. The present invention provides novel piperidinyl-cont...
2021 P/S Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical res...
Invention Piperidinyl nociceptin receptor compounds. The present invention provides novel piperidinyl-conta...
2018 Invention Selective high affinity alpha3beta4 nicotinic acetycholine receptor antagonists. Provided herein...
Invention Piperdinyl nociceptin receptor compounds. The present invention provides novel piperidinyl-contai...
2015 Invention Nicotinic acetylcholine receptor modulators. Provided herein are novel and selective high affinit...
2013 Invention Pain management in sickle cell anemia. The present invention relates to a method for the managem...